Patent · US Active

GPRC5D chimeric antigen receptors and cells expressing the same

US12077592B2 · kind B2 · utility

0Cited by
15References
36Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 15, 2020
Grant dateSep 3, 2024
Priority date
Expiry dateOct 23, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2510/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides for chimeric antigen receptors (CARs) that specifically target a G-protein coupled receptor, G-protein coupled receptor family C group 5 member D (GPRC5D), and immunoresponsive cells comprising such CARs, for the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.